Toxicology study begins
Just a few short months ago, in April 2020, Hope for Hasti commissioned the manufacture of three different vectors for use in our gene therapy study, the first ever gene therapy study undertaken for CdLS. These vectors are now ready for use thanks to Vigene Biosciences and their prompt manufacturing. These genetically engineered vectors, act a